Barclays Boosts Tenet Healthcare (NYSE:THC) Price Target to $171.00

Tenet Healthcare (NYSE:THC – Free Report) had its target price increased by Barclays from $156.00 to $171.00 in a report published on Monday morning, Benzinga reports. They currently have an overweight rating on the stock. THC has been the subject of a number of other reports. Robert W. Baird began coverage on Tenet Healthcare in […]

Leave a Reply

Your email address will not be published.

Previous post Guild Esports, backed by David Beckham, faces financial crisis after burning through £26.6M
Next post Wedbush Reiterates Outperform Rating for Unity Software (NYSE:U)